Francesco G. Salituro

5.3k total citations
45 papers, 1.8k citations indexed

About

Francesco G. Salituro is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Organic Chemistry. According to data from OpenAlex, Francesco G. Salituro has authored 45 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Molecular Biology, 17 papers in Cellular and Molecular Neuroscience and 10 papers in Organic Chemistry. Recurrent topics in Francesco G. Salituro's work include Neuroscience and Neuropharmacology Research (17 papers), Chemical Synthesis and Analysis (9 papers) and Receptor Mechanisms and Signaling (7 papers). Francesco G. Salituro is often cited by papers focused on Neuroscience and Neuropharmacology Research (17 papers), Chemical Synthesis and Analysis (9 papers) and Receptor Mechanisms and Signaling (7 papers). Francesco G. Salituro collaborates with scholars based in United States, China and Canada. Francesco G. Salituro's co-authors include Daniel H. Rich, Ian A. McDonald, Boyd L. Harrison, María‐Jesús Blanco, H. Steve White, T. Hofmann, Anita R. Sielecki, M. N. G. James, B M Baron and Mark W. Holladay and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Circulation Research.

In The Last Decade

Francesco G. Salituro

45 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Francesco G. Salituro United States	27	923	462	357	186	185	45	1.8k
Barbara Costa Italy	31	1.2k 1.3×	565 1.2×	586 1.6×	418 2.2×	101 0.5×	111	2.7k
Joseph B. Monahan United States	36	1.7k 1.8×	1.1k 2.3×	317 0.9×	313 1.7×	105 0.6×	76	3.4k
Mohammed A. Kashem United States	25	858 0.9×	456 1.0×	301 0.8×	157 0.8×	62 0.3×	58	1.8k
Celia Dominguez United States	27	1.1k 1.2×	412 0.9×	697 2.0×	233 1.3×	72 0.4×	79	2.2k
Brian Lockhart France	24	956 1.0×	450 1.0×	352 1.0×	138 0.7×	83 0.4×	51	2.0k
Lawrence P. Wennogle United States	30	1.7k 1.8×	761 1.6×	202 0.6×	202 1.1×	131 0.7×	69	2.6k
Magid Abou‐Gharbia United States	28	914 1.0×	319 0.7×	703 2.0×	198 1.1×	65 0.4×	112	2.3k
Jan Passchier United Kingdom	28	775 0.8×	488 1.1×	662 1.9×	262 1.4×	93 0.5×	67	2.8k
Timothy Harrison United Kingdom	25	1.1k 1.2×	611 1.3×	406 1.1×	217 1.2×	44 0.2×	52	1.7k
Shil Patel United States	29	1.3k 1.4×	1.1k 2.4×	471 1.3×	80 0.4×	84 0.5×	59	2.4k

Countries citing papers authored by Francesco G. Salituro

Since Specialization

Citations

This map shows the geographic impact of Francesco G. Salituro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Francesco G. Salituro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Francesco G. Salituro more than expected).

Fields of papers citing papers by Francesco G. Salituro

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Francesco G. Salituro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Francesco G. Salituro. The network helps show where Francesco G. Salituro may publish in the future.

Co-authorship network of co-authors of Francesco G. Salituro

This figure shows the co-authorship network connecting the top 25 collaborators of Francesco G. Salituro. A scholar is included among the top collaborators of Francesco G. Salituro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Francesco G. Salituro. Francesco G. Salituro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hill, Matthew D., María‐Jesús Blanco, Francesco G. Salituro, et al.. (2022). SAGE-718: A First-in-ClassN-Methyl-d-Aspartate Receptor Positive Allosteric Modulator for the Potential Treatment of Cognitive Impairment. Journal of Medicinal Chemistry. 65(13). 9063–9075. 28 indexed citations

Han, Bingsong, Francesco G. Salituro, & María‐Jesús Blanco. (2020). Impact of Allosteric Modulation in Drug Discovery: Innovation in Emerging Chemical Modalities. ACS Medicinal Chemistry Letters. 11(10). 1810–1819. 42 indexed citations

Youngblood, Brad, Yukie Ueyama, William W. Muir, et al.. (2018). A new method for determining levels of sedation in dogs: A pilot study with propofol and a novel neuroactive steroid anesthetic. Journal of Neuroscience Methods. 305. 82–88. 3 indexed citations

Hammond, Rebecca, Alison L. Althaus, Michael A. Ackley, et al.. (2017). Anticonvulsant profile of the neuroactive steroid, SGE-516, in animal models. Epilepsy Research. 134. 16–25. 19 indexed citations

Blanco, María‐Jesús, et al.. (2017). Breakthroughs in neuroactive steroid drug discovery. Bioorganic & Medicinal Chemistry Letters. 28(2). 61–70. 40 indexed citations

Salituro, Francesco G., Boyd L. Harrison, Richard T. Beresis, et al.. (2017). Neuroactive Steroids. 2. 3α-Hydroxy-3β-methyl-21-(4-cyano-1 H -pyrazol-1′-yl)-19-nor-5β-pregnan-20-one (SAGE-217): A Clinical Next Generation Neuroactive Steroid Positive Allosteric Modulator of the (γ-Aminobutyric Acid) _A Receptor. Journal of Medicinal Chemistry. 60(18). 7810–7819. 97 indexed citations

Martin, Brandon S., Gabriel Martínez-Botella, Carlos M. Loya, et al.. (2015). Rescue of deficient amygdala tonic γ‐aminobutyric acidergic currents in theFmr^–/ymouse model of fragile X syndrome by a novel γ‐aminobutyric acid type A receptor‐positive allosteric modulator. Journal of Neuroscience Research. 94(6). 568–578. 8 indexed citations

Popovici-Müller, Janeta, Jeffrey O. Saunders, Francesco G. Salituro, et al.. (2012). Discovery of the First Potent Inhibitors of Mutant IDH1 That Lower Tumor 2-HG in Vivo. ACS Medicinal Chemistry Letters. 3(10). 850–855. 160 indexed citations

Cao, Jingrong, Huai Gao, Guy W. Bemis, et al.. (2009). Structure-based design and parallel synthesis of N-benzyl isatin oximes as JNK3 MAP kinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 19(10). 2891–2895. 36 indexed citations

10.

Shao, Zhili, Kausik Bhattacharya, Eileen Hsich, et al.. (2005). c-Jun N-Terminal Kinases Mediate Reactivation of Akt and Cardiomyocyte Survival After Hypoxic Injury In Vitro and In Vivo. Circulation Research. 98(1). 111–118. 106 indexed citations

11.

Haar, Ernst ter, W. Patrick Walters, S. Pazhanisamy, et al.. (2004). Kinase Chemogenomics: Targeting the Human Kinome for Target Validation and Drug Discovery. Mini-Reviews in Medicinal Chemistry. 4(3). 235–253. 24 indexed citations

12.

Salituro, Francesco G., Ursula A. Germann, Keith P. Wilson, et al.. (1999). Inhibitors ofp38 MAP Kinase: TherapeuticIntervention inCytokine-Mediated Diseases. Current Medicinal Chemistry. 6(9). 807–823. 71 indexed citations

13.

Baker, Christopher, Francesco G. Salituro, John J. Court, et al.. (1998). Design, synthesis, and conformational analysis of a novel series of HIV protease inhibitors. Bioorganic & Medicinal Chemistry Letters. 8(24). 3631–3636. 15 indexed citations

14.

Baron, Bruce M., Boyd L. Harrison, John H. Kehne, et al.. (1997). Pharmacological characterization of MDL 105,519, an NMDA receptor glycine site antagonist. European Journal of Pharmacology. 323(2-3). 181–192. 40 indexed citations

15.

Wu, Hui‐Qiu, Francesco G. Salituro, & Robert Schwarcz. (1997). Enzyme-catalyzed production of the neuroprotective NMDA receptor antagonist 7-chlorokynurenic acid in the rat brain in vivo. European Journal of Pharmacology. 319(1). 13–20. 36 indexed citations

16.

Bitonti, Alan J., Jennifer Dumont, Francesco G. Salituro, et al.. (1996). Depletion of estrogen receptor in human breast tumor cells by a novel substituted indole that does not bind to the hormone binding domain. The Journal of Steroid Biochemistry and Molecular Biology. 58(1). 21–30. 3 indexed citations

17.

Kehne, John H., B M Baron, Boyd L. Harrison, et al.. (1995). MDL 100,458 and MDL 102,288: two potent and selective glycine receptor antagonists with different functional profiles. European Journal of Pharmacology. 284(1-2). 109–118. 32 indexed citations

18.

Salituro, Francesco G., Ronald Tomlinson, Bruce M. Baron, et al.. (1994). Enzyme-Activated Antagonists of the Strychnine-Insensitive Glycine/NMDA Receptor. Journal of Medicinal Chemistry. 37(3). 334–336. 35 indexed citations

19.

Salituro, Francesco G., Boyd L. Harrison, Bruce M. Baron, et al.. (1992). 3-(2-Carboxyindol-3-yl)propionic acid-based antagonists of the NMDA (N-methyl-D-aspartic acid) receptor associated glycine binding site. Journal of Medicinal Chemistry. 35(10). 1791–1799. 55 indexed citations

20.

Baron, B M, Francis P. Miller, Ian A. McDonald, et al.. (1990). Activity of 5,7-dichlorokynurenic acid, a potent antagonist at the N-methyl-D-aspartate receptor-associated glycine binding site.. Molecular Pharmacology. 38(4). 554–561. 96 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact